000 | 01063 a2200289 4500 | ||
---|---|---|---|
005 | 20250512050531.0 | ||
264 | 0 | _c19880603 | |
008 | 198806s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHerman, T S | |
245 | 0 | 0 |
_aSequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. _h[electronic resource] |
260 |
_bCancer research _cMay 1988 |
||
300 |
_a2693-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aFibrosarcoma _xpathology |
650 | 0 | 4 | _aHyperthermia, Induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
700 | 1 | _aTeicher, B A | |
773 | 0 |
_tCancer research _gvol. 48 _gno. 10 _gp. 2693-7 |
|
999 |
_c3365180 _d3365180 |